 |
Previous Article | Next Article 
The Journal of Neuroscience, May 1, 1998, 18(9):3213-3223
Stable Complexes Involving Acetylcholinesterase and Amyloid-
Peptide Change the Biochemical Properties of the Enzyme and Increase
the Neurotoxicity of Alzheimer's Fibrils
Alejandra
Alvarez1,
Rodrigo
Alarcón1,
Carlos
Opazo1,
Eliseo O.
Campos1,
Francisco José
Muñoz1,
Frances H.
Calderón1,
Federico
Dajas2,
Mary K.
Gentry3,
Bhupendra P.
Doctor3,
Fernando G.
De
Mello4, and
Nibaldo C.
Inestrosa1
1 Departamento de Biología Celular y Molecular,
Facultad de Ciencias Biológicas, Pontificia Universidad
Católica de Chile, Santiago, Chile, 2 División
de Neuroquímica, Instituto de Investigaciones Biológicas
Clemente Estable, Montevideo, Uruguay, 3 Division of
Biochemistry, Walter Reed Army Institute of Research, Washington, DC,
20307-5100, and 4 Instituto de Biofisica, Universidade
Federal do Rio de Janeiro, Rio de Janeiro, Brazil
Brain acetylcholinesterase (AChE) forms stable complexes with
amyloid- peptide (A ) during its assembly into filaments, in agreement with its colocalization with the A deposits of
Alzheimer's brain. The association of the enzyme with nascent A
aggregates occurs as early as after 30 min of incubation. Analysis of
the catalytic activity of the AChE incorporated into these complexes shows an anomalous behavior reminiscent of the AChE associated with
senile plaques, which includes a resistance to low pH, high substrate
concentrations, and lower sensitivity to AChE inhibitors. Furthermore,
the toxicity of the AChE-amyloid complexes is higher than that of the
A aggregates alone. Thus, in addition to its possible role as a
heterogeneous nucleator during amyloid formation, AChE, by forming such
stable complexes, may increase the neurotoxicity of A fibrils and
thus may determine the selective neuronal loss observed in Alzheimer's
brain.
Key words:
AChE; A -amyloid fibrils; AChE-A -amyloid fibril
complexes; amyloid formation; Alzheimer's disease; neurotoxicity
Copyright © 1998 Society for Neuroscience 0270-6474/98/1893213-11$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
G. I. Cancino, E. M. Toledo, N. R. Leal, D. E. Hernandez, L. F. Yevenes, N. C. Inestrosa, and A. R. Alvarez
STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's {beta}-amyloid deposits
Brain,
September 1, 2008;
131(9):
2425 - 2442.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Berson, M. Knobloch, M. Hanan, S. Diamant, M. Sharoni, D. Schuppli, B. C. Geyer, R. Ravid, T. S. Mor, R. M. Nitsch, et al.
Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology
Brain,
January 1, 2008;
131(1):
109 - 119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Diamant, E. Podoly, A. Friedler, H. Ligumsky, O. Livnah, and H. Soreq
Butyrylcholinesterase attenuates amyloid fibril formation in vitro
PNAS,
June 6, 2006;
103(23):
8628 - 8633.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Santos, R. A. Quintanilla, A. Toro, R. Grandy, M. C. Dinamarca, J. A. Godoy, and N. C. Inestrosa
Peroxisomal Proliferation Protects from {beta}-Amyloid Neurodegeneration
J. Biol. Chem.,
December 9, 2005;
280(49):
41057 - 41068.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Deschenes-Furry, G. Belanger, J. Mwanjewe, J. A. Lunde, R. J. Parks, N. Perrone-Bizzozero, and B. J. Jasmin
The RNA-binding Protein HuR Binds to Acetylcholinesterase Transcripts and Regulates Their Expression in Differentiating Skeletal Muscle Cells
J. Biol. Chem.,
July 8, 2005;
280(27):
25361 - 25368.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Quintanilla, F. J. Munoz, M. J. Metcalfe, M. Hitschfeld, G. Olivares, J. A. Godoy, and N. C. Inestrosa
Trolox and 17{beta}-Estradiol Protect against Amyloid {beta}-Peptide Neurotoxicity by a Mechanism That Involves Modulation of the Wnt Signaling Pathway
J. Biol. Chem.,
March 25, 2005;
280(12):
11615 - 11625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Reyes, M. A. Chacon, M. C. Dinamarca, W. Cerpa, C. Morgan, and N. C. Inestrosa
Acetylcholinesterase-A{beta} Complexes Are More Toxic than A{beta} Fibrils in Rat Hippocampus: Effect on Rat {beta}-Amyloid Aggregation, Laminin Expression, Reactive Astrocytosis, and Neuronal Cell Loss
Am. J. Pathol.,
June 1, 2004;
164(6):
2163 - 2174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. R. LOUZADA, A. C. P. LIMA, D. L. MENDONCA-SILVA, F. NOEL, F. G. DE MELLO, and S. T. FERREIRA
Taurine prevents the neurotoxicity of {beta}-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders
FASEB J,
March 1, 2004;
18(3):
511 - 518.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Munoz, C. Opazo, G. Gil-Gomez, G. Tapia, V. Fernandez, M. A. Valverde, and N. C. Inestrosa
Vitamin E But Not 17beta -Estradiol Protects against Vascular Toxicity Induced by beta -Amyloid Wild Type and the Dutch Amyloid Variant
J. Neurosci.,
April 15, 2002;
22(8):
3081 - 3089.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Bourne, P. Taylor, P. E. Bougis, and P. Marchot
Crystal Structure of Mouse Acetylcholinesterase. A PERIPHERAL SITE-OCCLUDING LOOP IN A TETRAMERIC ASSEMBLY
J. Biol. Chem.,
January 29, 1999;
274(5):
2963 - 2970.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|